Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAN ACNE Study
NCT07918001Phase 4Recruiting
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in acne vulgaris. Primary endpoint: Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs), Treatment-Related AEs and SAEs, and AEs Leading to Discontinuation at 12 weeks. Started Feb 2026; status: recruiting.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07918001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07918001.